The prognostic significance of the BRAF(V600E) mutation in papillary thyroid carcinoma detected by mutation-specific immunohistochemistry
Penelope A McKelvie, Fiona Chan, Yong Yu, Paul Waring, Irma Gresshoff, Stephen Farrell, Richard A Williams
Pathology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2013
Ventana Medical Systems provided reagents, loaned equipment and part salary to PW and IG for scientist (IG) to undertake this and other studies of the VE1 antibody. The other authors have no disclosures.